19 August 2026
19 August 2026
If sworn in by the Senate, Overton would take the helm during a tumultuous period for the agency defined by several resignations, firings and redundancies.
The partnership has so far provided Brukinsa to over 300 CLL patients in Armenia, Ethiopia, and Nepal.
The partnership aims to progress this gene therapy using Andelyn’s AAV Curator Platform.
Extra regulatory scrutiny is highly necessary when attempting to keep pace with the rapid biotechnological development in India.
This new guidance provides doctors in the UK with another important treatment option for heart failure (HF).
Tanabe’s dersimelagon is already under FDA review having achieved positive Phase III results earlier this year.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
